The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
Abstract
Mitogen-activated protein (MAP) kinases are 42- and 44-kD serine-threonine protein kinases that are activated by tyrosine and threonine phosphorylation in cells stimulated with mitogens and growth factors. MAP kinase and the protein kinase that activates it (MAP kinase kinase) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms (p35 EC12 , p37 22W ) of the c-Raf-1 protein kinase. The v-Raf proteins purified from cells infected with EC12 or 22W viruses activated MAP kinase kinase from skeletal muscle in vitro. Furthermore, a bacterially expressed v-Raf fusion protein (glutathione S-transferase-p37 22W ) also activated MAP kinase kinase in vitro. These findings suggest that one function of c-Raf-1 in mitogenic signaling is to phosphorylate and activate MAP kinase kinase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Raf-1 activates MAP kinase-kinase
Kyriakis, J. M., App, H., Zhang, X.-F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992) · Nature · doi:10.1038/358417a0 · Cited by 1,283
Payne, D. M., Rossomando, A. J., Martino, P., Erickson, A. K., Her, J. H., Shabanowitz, J., Hunt, D. F., Weber, M. J., & Sturgill, T. W. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08021.x · Cited by 1,040
Self-citationWood, K. W., Sarnecki, C., Roberts, T. M., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90076-o · Cited by 903
Self-citationThomas, S. M., DeMarco, M., D'Arcangelo, G., Halegoua, S., & Brugge, J. S. (1992) · Cell · doi:10.1016/0092-8674(92)90075-n · Cited by 676
Ray, L. B., & Sturgill, T. W. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.6.1502 · Cited by 592
Self-citationDissection of the protein kinase cascade by which nerve growth factor activates MAP kinases
Gómez, N., & Cohen, P. (1991) · Nature · doi:10.1038/353170a0 · Cited by 569
Raf-1 protein kinase is required for growth of induced NIH/3T3 cells
Kolch, W., Heidecker, G., Lloyd, P., & Rapp, U. R. (1991) · Nature · doi:10.1038/349426a0 · Cited by 474
Mitogen-activated protein kinases: versatile transducers for cell signaling
Pelech, S. L., & Sanghera, J. S. (1992) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)80005-5 · Cited by 428
Involvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387
Cited by
Items 101–114 of 114
Malarkey, K., Belham, C. M., Paul, A., Graham, A., McLees, A., Scott, P. H., & Plevin, R. (1995) · Biochemical Journal · doi:10.1042/bj3090361 · Cited by 268
Sale, E. M., Atkinson, P. G., & Sale, G. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07046.x · Cited by 266
Spaargaren, M., & Bischoff, J. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12609 · Cited by 265
The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer
Hilger, R. A., Scheulen, M. E., & Strumberg, D. (2002) · Oncology Research and Treatment · doi:10.1159/000068621 · Cited by 265
Induction of metaphase arrest in cleaving Xenopus embryos by MAP kinase
Haccard, O., Sarcevic, B., Lewellyn, A., Hartley, R., Roy, L., Izumi, T., Erikson, E., & Maller, J. (1993) · Science · doi:10.1126/science.8235656 · Cited by 261
The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.
Wartmann, M., & Davis, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37431-8 · Cited by 261
CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro.
Macdonald, S. G., Crews, C. M., Wu, L., Driller, J., Clark, R., Erikson, R. L., & McCormick, F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6615 · Cited by 252
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Büscher, D., Hipskind, R. A., Krautwald, S., Reimann, T., & Baccarini, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.466 · Cited by 176
“Activated Raf-1 in turn phosphorylates and activates MEK in vivo and in vitro (21, 39, 41, 48, 51, 82, 87).”
BackgroundUncoupling of Membrane Ruffling and Pinocytosis during Ras Signal Transduction
Li, G., D'Souza-Schorey, C., Barbieri, M. A., Cooper, J. A., & Stahl, P. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10337 · Cited by 85
Latimer, D. A., Gallo, J.-M., Lovestone, S., Miller, C. C. J., Hugh Reynolds, C., Marquardt, B., Stabel, S., Woodgett, J. R., & Anderton, B. H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00434-b · Cited by 48
Neuroprotective mechanisms of mangiferin in neurodegenerative diseases
Liu, T., Song, Y., & Hu, A. (2021) · Drug Development Research · doi:10.1002/ddr.21783 · Cited by 43
“ERK1/2 are considered to be activated by the Ras/Raf/MEK/ERK cascade, which are phosphorylated at both threonine and tyrosine residues at the regulatory sites (Dent et al., 1992; Zheng & Guan, 1993).”
BackgroundMontenegro, D. E., Franklin, T., Moscinski, L. C., Zuckerman, K. S., & Hu, X. ‐. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00567.x · Cited by 15
Metadata
- Authors
- Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M., & Sturgill, T. W.
- Venue
- Science
- Published
- 1992-09-04
- Volume
- 257
- Issue
- 5075
- Pages
- 1404-1407
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2009338295
- Cited by
- 668
- References
- 23
- FWCI
- 40.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.